Literature DB >> 26410377

The Eosinophil in Health and Disease: from Bench to Bedside and Back.

Wei Liao1, Hai Long1, Christopher Chia-Chi Chang2, Qianjin Lu3.   

Abstract

Historically, eosinophils have been considered as end-stage cells involved in host protection against parasitic infection and in the mechanisms of hypersensitivity. However, later studies have shown that this multifunctional cell is also capable of producing immunoregulatory cytokines and soluble mediators and is involved in tissue homeostasis and modulation of innate and adaptive immune responses. In this review, we summarize the biology of eosinophils, including the function and molecular mechanisms of their granule proteins, cell surface markers, mediators, and pathways, and present comprehensive reviews of research updates on the genetics and epigenetics of eosinophils. We describe recent advances in the development of epigenetics of eosinophil-related diseases, especially in asthma. Likewise, recent studies have provided us with a more complete appreciation of how eosinophils contribute to the pathogenesis of various diseases, including hypereosinophilic syndrome (HES). Over the past decades, the definition and criteria of HES have been evolving with the progress of our understanding of the disease and some aspects of this disease still remain controversial. We also review recent updates on the genetic and molecular mechanisms of HES, which have spurred dramatic developments in the clinical strategies of diagnosis and treatment for this heterogeneous group of diseases. The conclusion from this review is that the biology of eosinophils provides significant insights as to their roles in health and disease and, furthermore, demonstrates that a better understanding of eosinophil will accelerate the development of new therapeutic strategies for patients.

Entities:  

Keywords:  Asthma; Eosinophil; Eosinophilia; Epigenetics; Genetics; Hypereosinophilic syndrome; Inflammation

Mesh:

Substances:

Year:  2016        PMID: 26410377     DOI: 10.1007/s12016-015-8507-6

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  160 in total

1.  L-selectin-mediated lymphocyte rolling on MAdCAM-1.

Authors:  E L Berg; L M McEvoy; C Berlin; R F Bargatze; E C Butcher
Journal:  Nature       Date:  1993-12-16       Impact factor: 49.962

2.  PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors.

Authors:  C Nerlov; T Graf
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

Review 3.  Inhibition of interleukin-5 for the treatment of eosinophilic diseases.

Authors:  Jonathan Corren
Journal:  Discov Med       Date:  2012-04       Impact factor: 2.970

Review 4.  Clinical management of the hypereosinophilic syndromes.

Authors:  Elie Cogan; Florence Roufosse
Journal:  Expert Rev Hematol       Date:  2012-06       Impact factor: 2.929

5.  An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro.

Authors:  Hiromi Sugimoto; Michitaka Shichijo; Takashi Iino; Yoshihisa Manabe; Akihiko Watanabe; Makoto Shimazaki; Florian Gantner; Kevin B Bacon
Journal:  J Pharmacol Exp Ther       Date:  2003-04       Impact factor: 4.030

6.  A case of hypereosinophilic syndrome is associated with the expansion of a CD3-CD4+ T-cell population able to secrete large amounts of interleukin-5.

Authors:  D Brugnoni; P Airó; G Rossi; A Bettinardi; H U Simon; L Garza; C Tosoni; R Cattaneo; K Blaser; A Tucci
Journal:  Blood       Date:  1996-02-15       Impact factor: 22.113

7.  Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand.

Authors:  Hiroyuki Nagase; Shu Okugawa; Yasuo Ota; Masao Yamaguchi; Hideyuki Tomizawa; Kouji Matsushima; Ken Ohta; Kazuhiko Yamamoto; Koichi Hirai
Journal:  J Immunol       Date:  2003-10-15       Impact factor: 5.422

Review 8.  Effects of eosinophils on mast cells: a new pathway for the perpetuation of allergic inflammation.

Authors:  Adrian M Piliponsky; Gerald J Gleich; Ilan Bar; Francesca Levi-Schaffer
Journal:  Mol Immunol       Date:  2002-09       Impact factor: 4.407

9.  Essential and instructive roles of GATA factors in eosinophil development.

Authors:  Ryutaro Hirasawa; Ritsuko Shimizu; Satoru Takahashi; Mitsujiro Osawa; Shu Takayanagi; Yuko Kato; Masafumi Onodera; Naoko Minegishi; Masayuki Yamamoto; Katashi Fukao; Hideki Taniguchi; Hiromitsu Nakauchi; Atsushi Iwama
Journal:  J Exp Med       Date:  2002-06-03       Impact factor: 14.307

Review 10.  Requirement of macrophages and eosinophils and their cytokines/chemokines for mammary gland development.

Authors:  Valérie Gouon-Evans; Elaine Y Lin; Jeffrey W Pollard
Journal:  Breast Cancer Res       Date:  2002-06-25       Impact factor: 6.466

View more
  8 in total

Review 1.  Synergy of Interleukin (IL)-5 and IL-18 in eosinophil mediated pathogenesis of allergic diseases.

Authors:  Hemanth Kumar Kandikattu; Sathisha Upparahalli Venkateshaiah; Anil Mishra
Journal:  Cytokine Growth Factor Rev       Date:  2019-05-10       Impact factor: 7.638

2.  Rare Case of a Young Male Presented with Abdominal Pain, Solid Colon Tumors, and Eosinophilia, Followed by Tremendous Thromboembolic Complications and Eventually Diagnosed with Idiopathic Hypereosinophilic Syndrome.

Authors:  Tomasz Zemleduch; Anna Czapla; Piotr Kimla; Bartosz Kudliński
Journal:  Case Rep Med       Date:  2022-05-18

3.  The relationship between blood eosinophil count and disease activity in ankylosing spondylitis patients treated with TNF-α inhibitors.

Authors:  Gokhan Sargin; Taskin Senturk; Irfan Yavasoglu
Journal:  Saudi Pharm J       Date:  2018-05-04       Impact factor: 4.330

4.  Eosinophils in anti-neutrophil cytoplasmic antibody associated vasculitis.

Authors:  Thomas Hellmark; Sophie Ohlsson; Åsa Pettersson; Markus Hansson; Åsa C M Johansson
Journal:  BMC Rheumatol       Date:  2019-03-08

5.  Atomic Force Microscopy Is a Potent Technique to Study Eosinophil Activation.

Authors:  Peter Eaton; Constança Pais do Amaral; Shirley C P Couto; Mariangela S Oliveira; Andreanne G Vasconcelos; Tatiana K S Borges; Selma A S Kückelhaus; José Roberto S A Leite; Maria Imaculada Muniz-Junqueira
Journal:  Front Physiol       Date:  2019-10-01       Impact factor: 4.566

6.  Eosinophils: An imperative histopathological prognostic indicator for oral squamous cell carcinoma.

Authors:  G Deepthi; Pavan G Kulkarni; S R K Nandan
Journal:  J Oral Maxillofac Pathol       Date:  2019 May-Aug

7.  Paraneoplastic hypereosinophilia in a patient with peripheral T cell lymphoma, not otherwise specified.

Authors:  Minodora Desmirean; Dalma Deak; Ioana Rus; Delia Dima; Sabina Iluta; Alexandra Preda; Tiberiu Moldovan; Andrei Roman; Ciprian Tomuleasa; Bobe Petrushev
Journal:  Med Pharm Rep       Date:  2019-10-25

8.  Different Clusters in Patients with Chronic Obstructive Pulmonary Disease (COPD): A Two-Center Study in Brazil.

Authors:  José William Zucchi; Estefânia Aparecida Thomé Franco; Thomas Schreck; Maria Helena Castro E Silva; Sandro Rogerio Dos Santos Migliorini; Thaís Garcia; Gustavo Augusto Ferreira Mota; Bruna Evelyn Bueno de Morais; Luiz Henrique Soares Machado; Ana Natália Ribeiro Batista; Sergio Alberto Rupp de Paiva; Irma de Godoy; Suzana Erico Tanni
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-11-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.